Product Program year 2019 Source: CMS Open Payments

Ms Disease State

Drug

Open in the dashboard

General payments

$24,668

685 payments

Research payments

$0

0 payments

Through program year 2019, $24,668 in general payments and $0 in research payments were reported against Ms Disease State.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $24,668 685

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $24,353 678 payments
  2. Sanofi-Aventis U.S. LLC $315 7 payments
Top recipients General payments · program year 2019
  1. Derrick Robertson Neurology · Tampa, FL $445 2% · 7 payments
  2. Nida Laurin Neurology · Scottsdale, AZ $405 2% · 7 payments
  3. Angel Chinea Neurology · Guaynabo, PR $323 1% · 6 payments
  4. Annette Okai Neurology · Plano, TX $305 1% · 4 payments
  5. Daniel Becker Neurology · Lutherville, MD $286 1% · 11 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Neurology Psychiatry & Neurology $21,263 89% · 329 practitioners
  2. Clinical Neurophysiology Psychiatry & Neurology $535 2% · 6 practitioners
  3. Psychiatry Psychiatry & Neurology $328 1% · 3 practitioners
  4. Neuromuscular Medicine Psychiatry & Neurology $296 1% · 2 practitioners
  5. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $243 1% · 8 practitioners

The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Florida $2,639 11% · 30 recipients
  2. Pennsylvania $2,190 9% · 28 recipients
  3. Arizona $1,899 8% · 13 recipients
  4. California $1,576 6% · 34 recipients
  5. Texas $1,233 5% · 14 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

685 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record